Not applicableEnded earlyNCT01577264
What this trial is testing
Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)
Who this might be right for
Rheumatoid ArthritisCrohn's Disease
UCB Pharma 199